Our results indicate that treatments with CE and EAF, both at a 10% concentration, were able to regulate the metabolic imbalance caused by the tumor and inhibit the growth of ascitic and solid Ehrlich tumors by inducing apoptosis and modulating mast cells and the cytokines IL-6 and TNF-α. Here, IL6 is linked to Ehrlich tumor carcinoma.